TG Therapeutics Stock (NASDAQ: TGTX) stock price, news, charts, stock research, profile.
Open | $19.67 |
Close | - |
Volume / Avg. | 2.23M / 3.09M |
Day Range | 19.41 - 20.39 |
52 Wk Range | 6.46 - 26.95 |
Market Cap | $3.02B |
P/E Ratio | 65.17 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 70 |
Short Interest | 24.01% |
Days to Cover | 15.8 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of TG Therapeutics (NASDAQ:TGTX) through any online brokerage.
Other companies in TG Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), Ultragenyx Pharmaceutical (NASDAQ:RARE) and Avidity Biosciences (NASDAQ:RNA).
There is no analysis for TG Therapeutics.
TG Therapeutics has a consensus price target of $20.82.
The stock price for TG Therapeutics (NASDAQ: TGTX) is $19.98 last updated Today at July 9, 2024 at 3:32 PM EDT.
There are no upcoming dividends for TG Therapeutics.
TG Therapeutics’s Q2 earnings are confirmed for Tuesday, July 30, 2024.
There is no upcoming split for TG Therapeutics.
TG Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.